1Oberholzer A,Oberholzer C,Moldawer LL.Sepsis syndromes:Understanding the role of innate and acquired immunity.Shock,2001,16(2):83.
2Llewelyn M,Cohen J.New insights into the pathogenesis and therapy of sepsis and septic shock.Curr Clin Top Infect Dis,2001,21:148.
3Turnidge J.Impact of antibiotic resistance on the treatment of sepsis.Scand J Infect Dis,2003,35(9):677.
4Lepper PM,Held TK,Schneider EM et al.Clinical implications of antibiotic-induced endotoxin release in septic shock.Intensive Care Med,2002,28(7):824.
5Hynes-Gay P,Lalla P,Leo M et al.Understanding sepsis:From SIRS to septic shock.Dynamics,2002,13(1):17.
6Goldfarb RD,Parker TS,Levine DM et al.Protein-free phospholipid emulsion treatment improved cardiopulmonary function and survival in porcine sepsis.Am J Physiol Regul Integr Comp Physiol,2003,284(2):550.
7Shoji H.Extracorporeal endotoxin removal for the treatment of sepsis:Endotoxin adsorption cartridge(Toraymyxin).Therap Apher Dial,2003,7(1):108.
8Carraway MS,Welty-Wolf KE,Miller DL et al.Blockade of tissue factor:Treatment for organ injury in established sepsis.Am J Respir Crit Care Med,2003,167(9):1200.
9Remick DG.Cytokine therapeutics for the treatment of sepsis:Why has nothing worked? Curr Pharm Des,2003,9(1):75.
10Nasraway SA.The problems and challenges of immunotherapy in sepsis.Chest,2003,123(5 Suppl):451.
7Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care [J]. Crit Care Med,2001,29(7):1303-1310.
8Heithan TH, Kane BC, Mercer DW, et al. Postinjure multiple organ failure:the role of the gut[J]. Shock,2001, 15(1):1-10.
9Moore FA. The role of the gastrointestinal tract in postinjnry multiple organ failure[J]. Am J Surg,1999,178 (6):449-453.
10Wichterman KA, Baue AE, Chaudry IH. Sepsis and septic shock-a review of laboratory models and a proposal [J]. J Surg Res,1980,29(2):189-201.
